0000899243-20-016937.txt : 20200617
0000899243-20-016937.hdr.sgml : 20200617
20200617205552
ACCESSION NUMBER: 0000899243-20-016937
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200615
FILED AS OF DATE: 20200617
DATE AS OF CHANGE: 20200617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kornfeld Steven
CENTRAL INDEX KEY: 0001814653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 20971071
MAIL ADDRESS:
STREET 1: C/O FORTE BIOSCIENCES, INC.
STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forte Biosciences, Inc.
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 412-8400
MAIL ADDRESS:
STREET 1: 4242 CAMPUS POINT COURT, SUITE 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Tocagen Inc
DATE OF NAME CHANGE: 20071120
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-15
0
0001419041
Forte Biosciences, Inc.
FBRX
0001814653
Kornfeld Steven
C/O FORTE BIOSCIENCES, INC.
1124 W. CARSON STREET, MRL BLDG. 3-320
TORRANCE
CA
90502
1
0
0
0
Stock Option (right to buy)
18.90
2020-06-15
4
A
0
30000
0.00
A
2030-06-15
Common Stock
30000
30000
D
Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the Date of Grant. "Date of Grant" shall mean June 15, 2020.
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
2020-06-17